COMPANIES COVERED
HepalinkDownload FREE Report Sample
Download Free sampleHeparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.
Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
Heparin API Market is revolving around Heparin Active Pharmaceutical Ingredients (API).
Heparin API Market contains market size and forecasts of Heparin API in global, including the following market information:
Global Heparin API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Heparin API Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Heparin API companies in 2021 (%)
The global Heparin API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Heparin Sodium Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Heparin API include Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen Oss, King-friend Biochemical Pharmaceutical, Bioib?rica and Dongcheng Biochemicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Heparin API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Heparin API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Heparin API Market Segment Percentages, by Type, 2021 (%)
Heparin Sodium
Heparin Calcium
Other
Global Heparin API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Heparin API Market Segment Percentages, by Application, 2021 (%)
UFH
LMWH
Global Heparin API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Heparin API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Heparin API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Heparin API revenues share in global market, 2021 (%)
Key companies Heparin API sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Heparin API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioib?rica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma Limited
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
